GlassScriptPhysician profile
John Darren Beelitz
NPI 1003249566
$5,284.92
in general payments reported to CMS, 2019-2025
35 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,434 · 2020: $221 · 2022: $819 · 2023: $708 · 2024: $846 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,810.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,199.00 | 2019-2025 | Relistor |
| Nevro Corp. | $555.63 | 2019-2023 | Senza |
| Scilex Pharmaceuticals INC. | $485.84 | 2019-2024 | Ztlido |
| Collegium Pharmaceutical, INC. | $450.22 | 2019-2025 | Belbuca, Xtampza |
| Valinor Pharma, LLC | $364.66 | 2024-2025 | Movantik |
| Abbott Laboratories | $315.91 | 2019-2023 | Eterna |
| Si-Bone, INC. | $287.00 | 2019-2022 | |
| Daiichi Sankyo INC. | $213.45 | 2019 | |
| Vertos Medical, INC. | $180.37 | 2023-2024 | Mild Device Kit |
| Zynex Medical, INC. | $176.46 | 2023 | Nexwave |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $122.12 | 2023-2025 | Caplyta |
| Pfizer INC. | $87.51 | 2019 | |
| Abbvie INC. | $63.35 | 2022 | |
| Forte Bio-Pharma LLC | $56.22 | 2019-2024 | Prolate, Nalocet |
| Globus Medical, INC. | $55.18 | 2025 | Senza |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Beelitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.